当前位置:
首页
>
医学版
>
期刊论文
>
其它各类
>
加拿大医疗协会学报
>
2006年
>
第4期
: 共 42 篇
第4期
[
2006-7-22
]
A painful elbow?
[
2006-7-22
]
Measuring the presence of chronic diseases
[
2006-7-22
]
Unnecessary exposure?
[
2006-7-22
]
Unnecessary exposure?
[
2006-7-22
]
Reporting communicable diseases
[
2006-7-22
]
Measuring the presence of chronic diseases
[
2006-7-22
]
Standards of training
[
2006-7-22
]
Reflections from young physicians
[
2006-7-22
]
Reflections from young physicians
[
2006-7-22
]
Canadian Healing Oil
[
2006-7-22
]
Is this clinical trial fully registered?
[
2006-7-22
]
Do richer provinces have shorter waiting times to
[
2006-7-22
]
Training more doctors
[
2006-7-22
]
China borrows Canadian know-how for new labs
[
2006-7-22
]
Unnecessary exposure?
[
2006-7-22
]
Imaging techniques for coronary artery disease
[
2006-7-22
]
WTO's new rules allow poorest to import drugs
[
2006-7-22
]
An evaluation of class effect
[
2006-7-22
]
Is this clinical trial fully registered?
[
2006-7-22
]
Dans ce numéro
[
2006-7-22
]
The vexations of Vioxx
[
2006-7-22
]
Challenges for a Conservative minority
[
2006-7-22
]
Raising Lazarus
[
2006-7-22
]
An evaluation of class effect
[
2006-7-22
]
News a glance
[
2006-7-22
]
Standards of training
[
2006-7-22
]
Inflammation at a previous inoculation site: an un
[
2006-7-22
]
Bench to Bedside
[
2006-7-22
]
A sexual evolution
[
2006-7-22
]
Les journaux font-ils assez d'efforts pour préveni
[
2006-7-22
]
Bone infarcts in a woman with systemic lupus eryth
[
2006-7-22
]
The florist
[
2006-7-22
]
Changing epidemiology and emerging risk groups for
[
2006-7-22
]
Are journals doing enough to prevent fraudulent pu
[
2006-7-22
]
The association between elevated levels of inflamm
[
2006-7-22
]
Breast implant advisory panel: more study on silic
[
2006-7-22
]
Sources of bias in diagnostic accuracy studies and
[
2006-7-22
]
She's dying for help: global HIV
[
2006-7-22
]
Evidence of bias and variation in diagnostic accur
[
2006-7-22
]
New imaging techniques for diagnosing coronary art
[
2006-7-22
]
Relative value of multiple plasma biomarkers as ri
[
2006-7-22
]
Nonpatentable drugs and the cost of our ignorance